Evaluating diagnosis and treatment of oral and esophageal candidiasis in Ugandan AIDS patients

Emerging Infectious Diseases

Volumn 5, Issue 2, 1999, Pages 274-277

  Ravera, Maurizio ^a,b   Reggiori, Alberto ^a   Agliata, Anna Maria ^a   Rocco, Roberto Pidoto ^a  

^a Regional Teaching Hospital   (Uganda)

^b c/o AVSI ^*  (Uganda)

Author keywords

[No Author keywords available]

Indexed keywords

MICONAZOLE; NYSTATIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BIOPSY; CANDIDIASIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEVELOPING COUNTRY; DRUG EFFICACY; ENDOSCOPY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; RANDOMIZED CONTROLLED TRIAL; THRUSH; UGANDA;

EID: 0032933660     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0502.990214     Document Type: Article

References (29)

1. Wilcox CM, Karowe MW. Esophageal infections: etiology, diagnosis and management. Gastroenterologist 1994;2:188-206.
2. Lopez Dupla M, Mora Sanz P, Pintado Garcia V, Valencia Ortega E, Uriol PL, Khamashta MA, et al. Clinical, endoscopic, immunologic and therapeutic aspects of oropharyngeal and esophageal candidiasis in HIV infected patients: a survey of 114 cases. Am J Gastroenterol 1992;87:1771-6.
3. Sirera G, Clotet B, Romeu J. Incidence of opportunistic infections and malignancies in AIDS patients from Barcelona according to patients' risk behaviour. VII International Conference on AIDS, Florence Jun 16-21, 1991; M.B.2459 [abstract].
4. Heise W, Arasteh K, Mostertz P. Gastrointestinal manifestations in AIDS. Endoscopic, histological and microbiological aspects. VII International Conference on AIDS, Florence Jun 16-21, 1991:2227 [abstract].
5. Scevola D. Apparato gastrointestinale. In: Dianzani F, editor. Il libro italiano dell'AIDS. Milano: Mc Graw-Hill; 1994. p. 305-12.
6. Howlett WP, Nkya WM, Mmuni KA, Missalek WR Neurological disorders in AIDS and HIV disease in the northern zone of Tanzania. AIDS 1989;3:289-96.
7. Colebunders R, Latif AS. Natural history and clinical presentation of HIV-1 infection in adults. AIDS 1991;5 Suppl 1:3103-12.
8. Smith DE, Midgley J, Allan M, Connolly GM, Gazzard B. Itraconazole versus ketoconazole in the treatment of oral and oesophageal candidiasis in patients infected with HIV. AIDS 1991;5:1367-71.
9. Laine L, Bonacini M. Esophageal disease in HIV infection. Arch Intern Med 1994;154:1577-82.
10. Connolly GM, Hawkins D, Harcourt-Webster JN, Parsons PA, Husain OA, Gazzard BG. Oesophageal symptoms, their causes, treatment and prognosis in patients with the acquired immunodeficiency syndrome. Gut 1989;30:1033-9.
11. Mathieson R, Dutta SK. Candida esophagitis. Dig Dis Sci 1983;28:365-70.
12. Kodsi BE, Wickremesinghe PC, Kozinn PJ, Iswara K, Golberg PK. Candida esophagitis: a prospective study of 27 cases. Gastroenterology 1976;71:715-9.
13. Bonacini M, Young T, Laine L. The causes of esophageal symptoms in human immunodeficiency virus infection. A prospective study of 110 patients. Arch Intern Med 1991;151:1567-72.
14. Bianchi Porro G, Parente F, Cernuschi M. The diagnosis of oesophageal candidiasis in patients with the acquired immune deficiency syndrome: is endoscopy always necessary? Am J Gastroenterol 1989,84:143-6.
15. Pons V, Greenspan D, Debruin M. Therapy for oropharyngeal candidiasis in HIV infected patients: a randomized, prospective multicenter study group. Journal of Acquired Immune Deficiency Syndrome 1993;6:1311-6.
16. Greenspan D. Treatment of oropharyngeal candidiasis m HIV positive patients. J Am Acad Dermatol 1994;31:S51-5.
17. Hernandez Sampelayo T. Fluconazole versus ketoconazole in the treatment of oropharyngeal candidiasis in HIV infected children multicenter study group. Eur J Clin Microbiol Infect Dis 1994;13:340-4.
18. Gil A, Lavilla P, Lopez Dupla M, Valencia E, Pintado V, Khamashta M, et al. Treatment of esophageal candidiasis with fluconazole in acquired immunodeficiency syndrome. Comparative study of 2 therapeutic schemes. Med Clin (Barc) 1992;98:612-7.
19. Berger TG. Treatment of bacterial, fungal and parasitic infections in the HIV infected host. Seminar in Dermatology 1993;12:296-300.
20. Sutton FM, Graham DY, Goodgame RW. Infectious esophagitis. Gastrointest EndoscClinNAm 1994;4:713-29.
21. Soubry R, Clerinx J, Banyangiliki V. Comparison of itraconazole oral solution and fluconazole capsules in the treatment of oral and esophageal candidiasis in HIV infected patients. Preliminary results. VII International Conference on AIDS, Florence 16-21 Jun, 1991: M.B. 2201 [abstract].
22. De Wit S. Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDS. Lancet 1989;1:746-8.
23. Laine L, Dretler RH, Conteas CN, Tuazon C, Koster FM, Sattler F, et al. Fluconazole compared with ketoconazole for the treatment of candida esophagitis in AIDS. A randomized trial. Ann Intern Med 1992;117:655-60.
24. Nyst MJ, Perriens JH, Kimputu L, Lumbila M, Nelson AM, Piot P. Gentian violet, ketoconazole and nystatin in oropharyngeal and esophageal candidiasis in Zairean AIDS patients. Annales de la Societé Belge de Médecine Tropicale 1992;72:45-52.
25. Grahame-Smith DG, Aronson JK. Oxford textbook of clinical pharmacology and drug therapy. 2nd ed. New York: Oxford University Press Inc.; 1992. p. 559.
26. Raufman JP, Rosenthal LE. Oral candidiasis as a marker for esophageal candidiasis in the acquired immunodeficiency syndrome. Ann Intern Med 1986;104:54-8.
27. Bassetti D, Canessa A. Micosi. In: Ferdinando Dianzani, editor. Il libro italiano dell'AIDS. Milano: Mc Graw-Hill; 1994. p. 224-8.
28. Parente F, Cerruschi M, Rizzardini G, Lazzarin A, Valsecchi L, Bianchi Porro G. Opportunistic infections of the esophagus not responding to oral systemic antifungals in patients with AIDS: their frequency and treatment. Am J Gastroenterol 1991;86:1729-34.
29. Holt RJ, Azmi A. Miconazole resistant candida. Lancet 1978;1:50-1.